OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Lucas Morin, Kristina Johnell, Marie‐Laure Laroche, et al.
Clinical Epidemiology (2018) Vol. Volume 10, pp. 289-298
Open Access | Times Cited: 301

Showing 1-25 of 301 citing articles:

An update on the clinical consequences of polypharmacy in older adults: a narrative review
Jonas W. Wastesson, Lucas Morin, Edwin C.K. Tan, et al.
Expert Opinion on Drug Safety (2018) Vol. 17, Iss. 12, pp. 1185-1196
Open Access | Times Cited: 452

An overview of prevalence, determinants and health outcomes of polypharmacy
Mina Khezrian, Christopher J. McNeil, Alison D. Murray, et al.
Therapeutic Advances in Drug Safety (2020) Vol. 11
Open Access | Times Cited: 314

Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Farhad Pazan, Martin Wehling
European Geriatric Medicine (2021) Vol. 12, Iss. 3, pp. 443-452
Open Access | Times Cited: 270

The Healthy Microbiome—What Is the Definition of a Healthy Gut Microbiome?
Fergus Shanahan, Tarini Shankar Ghosh, Paul W. O’Toole
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 483-494
Closed Access | Times Cited: 261

Culture as a cure
Katherine De Bienassis, Solvejg Kristensen, Magdalena Burtscher, et al.
OECD health working papers (2020)
Open Access | Times Cited: 227

Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis
Mahin Delara, Lauren Murray, Behnaz Jafari, et al.
BMC Geriatrics (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 174

Barriers and facilitators to deprescribing in primary care: a systematic review
Alison Jayne Doherty, Paul Boland, Janet Reed, et al.
BJGP Open (2020) Vol. 4, Iss. 3, pp. bjgpopen20X101096-bjgpopen20X101096
Open Access | Times Cited: 156

The economics of medication safety
Katherine De Bienassis, Laura Esmail, Ruth Lopert, et al.
OECD health working papers (2022)
Open Access | Times Cited: 137

Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review
Kathryn Nicholson, Winnie Liu, Daire W. D. Fitzpatrick, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 4, pp. e287-e296
Open Access | Times Cited: 30

Proactive Polypharmacy Management Using Large Language Models: Opportunities to Enhance Geriatric Care
Arya Rao, John Kim, Winston Lie, et al.
Journal of Medical Systems (2024) Vol. 48, Iss. 1
Closed Access | Times Cited: 17

Effects of warning information at medication initiation on deprescribing intentions in older adults: A hypothetical vignette
Sarah E. Vordenberg, Kari Ostaszewski, Vincent D. Marshall, et al.
Patient Education and Counseling (2025) Vol. 133, pp. 108654-108654
Closed Access | Times Cited: 2

Antibiotic Use and Risk of Microscopic Colitis in Older Adults: A Nationwide Self‐Controlled Case Series Study
Máté Szilcz, Jonas W. Wastesson, David Bergman, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 2

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
Insa M. Schmidt, Sílvia de Oliveira Hübner, Jennifer Nadal, et al.
Clinical Kidney Journal (2019) Vol. 12, Iss. 5, pp. 663-672
Open Access | Times Cited: 118

Hypertension and Drug Adherence in the Elderly
Michel Burnier, Erietta Polychronopoulou, Grégoire Wuerzner
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 95

Incidence of and Risk Factors for Hepatic Encephalopathy in a Population‐Based Cohort of Americans With Cirrhosis
Elliot B. Tapper, James Henderson, Neehar D. Parikh, et al.
Hepatology Communications (2019) Vol. 3, Iss. 11, pp. 1510-1519
Open Access | Times Cited: 94

“Inactive” ingredients in oral medications
Daniel Reker, Steven M. Blum, Christoph Steiger, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 483
Open Access | Times Cited: 93

Polypharmacy: A general review of definitions, descriptions and determinants
Jordan Guillot, Sandy Maumus-Robert, Julien Bezin
Therapies (2019) Vol. 75, Iss. 5, pp. 407-416
Open Access | Times Cited: 90

Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis
Widya N. Insani, Cate Whittlesea, Hassan Alwafi, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0252161-e0252161
Open Access | Times Cited: 78

An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study
Naiqi Zhang, Jan Sundquist, Kristina Sundquist, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 76

The economics of patient safety Part III: Long-term care
Katherine De Bienassis, Ana Llena‐Nozal, Nicolaas S. Klazinga
OECD health working papers (2020)
Open Access | Times Cited: 73

Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions
Marta Kurczewska-Michalak, Paweł Lewek, Beata Jankowska‐Polańska, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 62

The use of general anaesthesia in special care dentistry: A clinical guideline from the British Society for Disability and Oral Health
Andrew Geddis‐Regan, Deborah Gray, Sarah Buckingham, et al.
Special Care in Dentistry (2022) Vol. 42, Iss. S1, pp. 3-32
Open Access | Times Cited: 44

Page 1 - Next Page

Scroll to top